Difference between early onset and late-onset pediatric ulcerative colitis

Ryusuke Nambu1, Shin-Ichiro Hagiwara2, Mitsuru Kubota2

  • 1Division of General Pediatrics, Saitama Children's Medical Center, Saitama, Japan. nambee1231@gmail.com.

Insights

Early onset pediatric ulcerative colitis (EO-UC) presents with more pancolitis and extra-intestinal issues, often with a longer diagnostic delay compared to late onset UC. Diagnosis and treatment can be more challenging for EO-UC patients.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Early onset ulcerative colitis (EO-UC) differs from late onset UC (LO-UC) due to genetic factors.
  • Limited data exists on EO-UC clinical features in Asian populations.

Purpose of the Study:

  • To compare the clinical presentation and disease course of EO-UC (0-7 years) with LO-UC (8-15 years).
  • To identify differences in diagnosis, disease extent, and complications between EO-UC and LO-UC.

Main Methods:

  • Retrospective analysis of 63 pediatric UC patients diagnosed between 2004-2014 in Japan.
  • Comparison of EO-UC (n=10) and LO-UC (n=53) groups based on clinical data.

Main Results:

  • EO-UC patients showed a higher incidence of pancolitis (100% vs 70%) compared to LO-UC.
  • Diagnostic delay was significantly longer in EO-UC (9.0 months vs 2.6 months).
  • Extra-intestinal complications were more prevalent in EO-UC (50% vs 11%) at diagnosis.

Conclusions:

  • EO-UC is associated with pancolitis, delayed diagnosis, and increased extra-intestinal manifestations.
  • Diagnosis and management of EO-UC may present greater challenges than LO-UC.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
901
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
27
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
697
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
833